1 - 5 of 5 Results Clear All
Gladstone researchers talk about the power of iPS cells in biomedical research
Stem Cells/iPSCs Cardiovascular Disease Stem Cell Core
San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.
Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab Ott Lab Yamanaka Lab Organoids
Gladstone researchers used a machine-learning approach to discover new ways of controlling the spatial organization of induced pluripotent stem cells.
News Release Research (Publication) Histology and Light Microscopy Core Stem Cell Core Conklin Lab McDevitt Lab AI Big Data CRISPR/Gene Editing Imaging
Since Shinya Yamanaka discovered a method to create human induced pluripotent stem (iPS) cells, Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.
Research (Publication) Stem Cell Core Huntington’s Disease Alzheimer’s Disease Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing
Wendy explains how being rejected for a lab position led her to work in what she describes as “zookeeping for cells.” She also talks about her Masters Swimming skills and how she developed her secret talent for cake decoration.
Profile Stem Cell Core Stem Cells/iPSCs
